Matches in Nanopublications for { ?s ?p "[Finally, SLC16A12, GALR2, TOX, SPOCK2, EGFR5 and DPYS are candidate biomarkers for breast cancer (methylation range 33%-79%) with the combination of EGFR5 or TOX hypermethylation showing a sensitivity of 92% and specificity of 92%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP668564.RAhv5uERBmHpT1BEYbpVZfZOOooFgVM92eNii0F46to-M130_assertion description "[Finally, SLC16A12, GALR2, TOX, SPOCK2, EGFR5 and DPYS are candidate biomarkers for breast cancer (methylation range 33%-79%) with the combination of EGFR5 or TOX hypermethylation showing a sensitivity of 92% and specificity of 92%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668564.RAhv5uERBmHpT1BEYbpVZfZOOooFgVM92eNii0F46to-M130_provenance.